Phosphodiesterase Inhibitors: Mechanism, Uses, and Safety
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Phosphodiesterase (PDE) inhibitors are a diverse class of medications that block specific enzymes to relax blood vessels and reduce inflammation. While widely recognized for treating erectile dysfunction, they are also critical for managing heart failure, pulmonary hypertension, and inflammatory skin conditions like eczema. These medications come in oral, topical, and intravenous forms, offering targeted treatment options for various circulatory and respiratory disorders.
Quick Answer
Phosphodiesterase inhibitors are medications that block phosphodiesterase enzymes, allowing blood vessels to relax and widen, which improves blood flow, lowers blood pressure and reduces inflammation. They are FDA-approved to treat over a dozen conditions, ranging from heart failure and chronic obstructive pulmonary disease (COPD) to erectile dysfunction and psoriasis. [1]
What the research says
PDE-5 inhibitors work well for erectile dysfunction, even after spinal cord injury. A network meta-analysis of 10 randomized trials in 1,492 men with spinal cord injury found PDE-5 inhibitors were about four times more effective than placebo at improving erectile function (risk ratio 4.13, 95% CI 2.76 to 6.19), with tadalafil ranking highest (SUCRA 81%) (Tienforti et al., Andrology, 2025).
Sildenafil improves exercise capacity and lung pressures in pulmonary arterial hypertension. In a meta-analysis of 10 studies and 480 adult Asian patients, sildenafil 20 mg three times daily added 57.68 meters to six-minute walk distance (95% CI 41.55 to 73.81) and lowered mean pulmonary artery pressure by 4.13 mmHg (95% CI 1.74 to 6.52). Headache, flushing, dyspepsia, and diarrhea were the most common side effects and were relatively mild (Shi et al., Ann Palliat Med, 2022).
A PDE-4 inhibitor clears skin better than placebo in plaque psoriasis. A meta-analysis of placebo-controlled trials found roflumilast raised the chance of reaching clear or almost clear skin (Investigator's Global Assessment of 0 or 1) about 3.5-fold at week 4 (RR 3.48, 95% CI 2.04 to 5.92) and about 4-fold at week 8 (RR 4.02, 95% CI 3.17 to 5.11) (Aleid et al., Curr Drug Saf, 2026).
Research summaries are based on article abstracts retrieved from PubMed.
How do phosphodiesterase (PDE) inhibitors work?
Phosphodiesterase (PDE) inhibitors function by blocking enzymes that regulate chemical reactions within the blood and tissues. These enzymes, known as phosphodiesterases, typically speed up the breakdown of molecules that help muscles relax. When these enzymes are inhibited, blood vessels can widen more easily, improving circulation and reducing the workload on the heart. [1]
The Role of Different PDE Enzymes
Human bodies contain several types of phosphodiesterases, each located in specific areas and serving distinct functions. Selective PDE inhibitors are designed to target one specific type, while nonselective inhibitors may affect multiple enzymes throughout the body.
PDE Type | Primary Location | Biological Role |
PDE-3 | Heart and Circulatory System | Regulates heart muscle contraction and blood clotting. |
PDE-4 | Lungs and Airway Muscles | Influences airway constriction and inflammatory responses. |
PDE-5 | Lungs and Penis | Controls blood vessel relaxation in pulmonary and reproductive tissues. |
What are phosphodiesterase inhibitors commonly used for?
Because these medications influence both circulation and inflammation, they are utilized across several medical specialties. The FDA has approved PDE inhibitors for more than 12 different conditions, highlighting their versatility in modern medicine.
Cardiovascular and Circulatory Health
In the heart and circulatory system, PDE inhibitors help manage conditions where blood flow is restricted or the heart is under significant stress.
Heart Failure Management: Used for decompensated heart failure when the heart is too weak to pump effectively.
Pulmonary Hypertension: Helps lower high blood pressure specifically within the lungs.
Clotting Prevention: Dipyridamole and other PDE-3 inhibitors are used after surgery to prevent dangerous blood clots that could lead to strokes or heart attacks.
Respiratory and Inflammatory Conditions
PDE-4 inhibitors are particularly effective at reducing inflammation, making them valuable for treating chronic lung diseases and skin disorders.
Chronic Obstructive Pulmonary Disease (COPD): Roflumilast helps reduce airway inflammation in patients with severe lung disease.
Skin Disorders: Topical PDE-4 inhibitors like crisaborole are used to treat eczema (atopic dermatitis) by reducing localized inflammation.
Joint Health: Apremilast is commonly prescribed for psoriatic arthritis to manage systemic inflammation.
Which phosphodiesterase (PDE) inhibitors are FDA-approved, by class?
As of September 2021, there are 14 PDE inhibitors with FDA approval, categorized by the specific enzyme they target. [1]
Class | Generic Medication Names |
PDE-3 Inhibitors | Amrinone, Anagrelide, Cilostazol, Dipyridamole, Milrinone |
PDE-4 Inhibitors | Apremilast, Crisaborole, Roflumilast |
PDE-5 Inhibitors | Avanafil, Sildenafil, Tadalafil, Vardenafil |
Non-selective | Caffeine, Pentoxifylline, Theophylline |
What are the safety risks and side effects of PDE inhibitors?
PDE inhibitors carry risks that vary with the specific enzyme targeted, including side effects and critical drug interactions. Patients should be aware of common reactions and critical drug interactions.
PDE-5 Specific Warnings
A critical safety warning exists for PDE-5 inhibitors (such as sildenafil or tadalafil). These must never be taken with nitroglycerin, as the combination can cause a dangerous drop in blood pressure. Additionally, a rare but serious side effect called priapism, a prolonged erection lasting more than four hours, requires immediate medical attention. [1]
General Side Effects
PDE-3: May cause low platelet counts, headaches, or irregular heart rhythms (arrhythmia). Cilostazol carries an FDA boxed warning: it must not be used by anyone with heart failure of any severity.
PDE-4: Commonly associated with gastrointestinal issues like nausea, diarrhea, or weight loss.
PDE-5: Can cause flushed skin, nasal congestion, or temporary vision and hearing changes. [1]
Conclusion
Phosphodiesterase inhibitors represent a versatile class of drugs that provide essential relief for millions of patients. From restoring circulatory function to managing chronic inflammatory diseases, these medications offer targeted solutions for complex health challenges. If you believe you may benefit from this therapy, consult with a healthcare provider to discuss which selective or nonselective inhibitor is right for your specific needs. Do not take any of these medications without a prescription.
Frequently Asked Questions
What are the most common PDE-5 inhibitors?
The most widely prescribed PDE-5 inhibitors are sildenafil (Viagra®) and tadalafil (Cialis®). These medications are frequently used to treat erectile dysfunction and pulmonary hypertension, with millions of prescriptions filled annually in the United States.
Can PDE inhibitors be used for skin conditions?
Yes, certain PDE-4 inhibitors are specifically designed for skin health. Crisaborole is a topical ointment used to treat eczema, while apremilast is an oral medication used for psoriasis and psoriatic arthritis.
How do PDE-3 inhibitors help the heart?
PDE-3 inhibitors like milrinone help the heart by increasing the strength of heart muscle contractions and relaxing blood vessels. This reduces the effort required for the heart to pump blood, which is vital during heart failure.
Are there non-prescription PDE inhibitors?
Caffeine is a well-known non-selective phosphodiesterase inhibitor. While it occurs naturally in coffee and tea, medicinal forms like caffeine citrate are used in hospitals to treat neonatal apnea in premature newborns.
What is the difference between selective and non-selective inhibitors?
Selective inhibitors target one specific type of enzyme (like PDE-5), which helps reduce side effects in other parts of the body. Non-selective inhibitors affect multiple PDE enzymes at once, which can be useful for broader systemic effects but may increase the variety of side effects.
Is weight loss a side effect of these drugs?
Weight loss and reduced appetite are known side effects associated with PDE-4 inhibitors like apremilast and roflumilast. Patients taking these medications for COPD or psoriasis should monitor their weight and report significant changes to their doctor.
Can I take PDE-5 inhibitors if I have heart disease?
It depends on your specific condition and other medications, so always check with your doctor first. PDE-5 inhibitors are not recommended for high-risk heart conditions such as unstable angina, severe heart failure, a recent heart attack, or serious heart rhythm problems. They must never be combined with nitrates (like nitroglycerin) for chest pain.
What should I do if I experience vision changes?
If you experience sudden changes in vision or hearing while taking a PDE-5 inhibitor, you should stop the medication immediately and contact a healthcare professional, as these can be signs of a rare but serious complication.
How are these medications administered?
PDE inhibitors are available in multiple forms to suit different needs. They can be taken as oral tablets, applied as topical creams for skin conditions, or administered via intravenous (IV) injection in a hospital setting.
Do PDE inhibitors treat lung diseases?
Yes, PDE-4 inhibitors like roflumilast are used to treat chronic obstructive pulmonary disease (COPD), while PDE-5 inhibitors like sildenafil are used to treat pulmonary hypertension (high blood pressure in the lungs).
Related Reading
Erectile Dysfunction: Symptoms, Causes, and Treatment covers erectile problems, a common use for PDE-5 inhibitors.
Pulmonary Arterial Hypertension: Symptoms, Causes, and Care explains high lung blood pressure, also treated with PDE-5 inhibitors.
What Is Chronic Obstructive Pulmonary Disease (COPD)? Symptoms, Causes, Stages, and Treatment covers COPD, which a PDE-4 inhibitor can help manage.
Psoriasis: Complete Guide to Symptoms, Types, Causes, and Treatment explains psoriasis and its treatments, including oral PDE-4 inhibitors.
References
Cleveland Clinic. Phosphodiesterase Inhibitors. Cleveland Clinic Health Library. Last updated June 8, 2022. https://my.clevelandclinic.org/health/treatments/23211-phosphodiesterase-inhibitors
Tienforti D, Felzani G, Di Pasquale AB, et al. Which PDE5 inhibitor is the most effective in the treatment of erectile dysfunction in men with spinal cord injury? A systematic review and network meta-analysis. Andrology. 2025;13(2):314-322. PMID: 38554048. DOI: 10.1111/andr.13642
Shi Q, Wang Z, Yang N, et al. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Ann Palliat Med. 2022;11(1):339-351. PMID: 35144425. DOI: 10.21037/apm-21-3979
Aleid AM, Mohammed Alshreef S, Tariq Alrubaiaan M, et al. Effectiveness and safety of roflumilast in the treatment of psoriasis: a systematic review and meta-analysis. Curr Drug Saf. 2026;21(5):e15748863406187. PMID: 41691689. DOI: 10.2174/0115748863406187251031101244
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have about a medical condition.
Comments